Related Experiment Video

Updated: Aug 16, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium

Ariela Noy1, Shelly Y Lensing2, Page C Moore2

  • 1a Memorial Sloan-Kettering Cancer Center, and Weill-Cornell Medical College New York , NY , USA ;

Leukemia & Lymphoma
|December 18, 2015
PubMed
Abstract

No abstract available in PubMed .

Keywords:
HIVhighly active antiretroviral therapylymphomaplasmablastic

More Related Videos

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Related Experiment Videos

Last Updated: Aug 16, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Articles linked to this work by shared authors, journal, and citation graph.

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab.

Pediatric blood & cancer·2026

New Paradigms in the Management of Castleman Disease.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Clinical outcomes, patterns of relapse, and molecular landscape of advanced stage high-grade B-cell lymphoma.

Blood advances·2026

Spatial remodeling of bone marrow architecture defines tissue-state signatures of disease activity and therapeutic response in myelodysplastic neoplasms.

Leukemia·2026

Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKs.

Blood advances·2026

eIF3e-mediated translational checkpoint maintains immune tolerance and prevents lymphoid malignancy.

The Journal of experimental medicine·2026

Diagnostic accuracy and clinical usefulness of lung ultrasound in onco hematological patients with neutropenic fever.

Leukemia & lymphoma·2026

Prognostic factors and survival in HHV8 positive diffuse large B cell lymphoma: a national cancer database analysis.

Leukemia & lymphoma·2026

Adverse events, quality of life, and work impairment in patients with chronic myeloid leukemia (CML)-a survey of first- and second-line tyrosine kinase inhibitor (TKI) intolerance in the US.

Leukemia & lymphoma·2026

Usefulness of 20-mm incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma: a single-center experience.

Leukemia & lymphoma·2026

MRD-guided induction-intensification with daratumumab-carfilzomib-based regimen followed by ASCT in patients with newly diagnosed multiple myeloma.

Leukemia & lymphoma·2026

Revisiting invasive fungal infections in acute lymphoblastic leukemia: a systematic review and meta-analysis.

Leukemia & lymphoma·2026

Platelet indices and incident hypertension: effect modification by body mass index in a Chinese cohort.

Journal of global health·2026

Advancements in CRISPR-based in vivo gene therapy for hemophilia.

Frontiers in genome editing·2026

Assessing intra- and inter-analyser imprecision in automated hematological laboratories.

Journal of medical biochemistry·2026

Treatment of Deep Vein Thrombosis in Congenital Factor VII Deficiency: A Case Report and Literature Review.

Clinical case reports·2026

Intermittent Hematuria and Shock due to Uretero-Arterial Fistula Diagnosed by Provocative Angiography.

Annals of vascular diseases·2026

Complement diagnostics and therapeutics for the pediatric population: early successes and opportunities for further advancement.

Frontiers in pharmacology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us